Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexamethasone in COVID-19
NCT04513184Phase 2Completed
- Start
- Nov 2021
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in coronavirus disease 2019 (COVID-19). Started Nov 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04513184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04513184.